Association of Type 2 Diabetes With Cyclooxygenase-Mediated Inflammation and Oxidative Stress in an Elderly Population
- 13 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (14) , 1729-1734
- https://doi.org/10.1161/01.cir.0000124718.99562.91
Abstract
Background— Involvement of cyclooxygenase (COX)-mediated inflammation in type 2 diabetes has not been studied, and the association between cytokine-mediated inflammation and diabetes is not fully clarified.Keywords
This publication has 27 references indexed in Scilit:
- Do atherosclerosis and type 2 diabetes share a common inflammatory basis?European Heart Journal, 2002
- Association between C-reactive protein and features of the metabolic syndrome: a population-based study.Diabetes Care, 2000
- Low grade inflammation and coronary heart disease: prospective study and updated meta-analysesBMJ, 2000
- Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrestFEBS Letters, 2000
- Oxidative stress and diabetes mellitusEuropean Journal of Internal Medicine, 1999
- Oxidative injury and survival during endotoxemiaFEBS Letters, 1998
- Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2α: an index for inflammation via cyclooxygenase catalysed lipid peroxidationProstaglandins, Leukotrienes & Essential Fatty Acids, 1998
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.Proceedings of the National Academy of Sciences, 1990
- Increased levels of acute-phase serum proteins in diabetesMetabolism, 1989